Global

Pharmaceutical Sciences Experts

John Murray


Non-Executive Chairman
Latrobe Magnesium Ltd
Australia

Biography

Mr. John S. Murray has been appointed as Non-Executive Chairman of the Board of Latrobe Magnesium Limited., effective 10 April 2015. Mr Murray brings a wealth of senior management and directorship experience with a particular focus on infrastructure, project management and freight logistics projects. In addition to high profile roles surrounding transportation for the Sydney Olympic Games he acted as an adviser for operational planning and infrastructure for the Beijing and London Olympic Games. Mr Murray managed numerous large projects in his role with New South Wales Department for Transport including the production of a 10 year development plan for the state’s transport infrastructure and services as well as chairing the $2 billion Parramatta Rail Link Company project. Roles currently held by Mr Murray include strategic adviser for law firm King & Wood Mallesons in the government infrastructure sector, consulting for engineering company GHD and non-executive chairman of bulk liquid road tank manufacturer Omnitankers. In addition to these roles Mr Murray has held numerous directorships including nonexecutive chairman for The Hills Motorway (M2) Limited prior to its takeover by Transurban in 2005. The non-executive chairman for Country Pipelines for the three years prior to its takeover by APA in 2008. He was also on the board of Director Terminals Australia for five years up until its sale to Asciano in 2008. Prior to his foray into business Mr Murray had a decorated military career over almost 30 years including squadron command in the Australian Special Air Services before retiring as a Colonel in 1994. Mr Murray studied economics and history with the Royal Military College at Duntroon before completing a graduate diploma in engineering management at the Royal Military College of Science in the UK. He also holds qualifications in international politics from Deakin University and has completed the company directors’ course and two finance courses with the Australian Institute of Company Directors.

Research Interest

  Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management  

Global Experts from Australia

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Kalpana Datta
    Kalpana Datta
    Assistant Professor
    Department of Pediatrics
    Chittaranjan National Cancer Institute
    India
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates